Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Co-Diagnostics, Inc. develops and manufactures molecular diagnostic tests using proprietary PCR technology to detect infectious diseases and genetic traits. Its core products include PCR-based diagnostic kits for COVID-19, influenza, tuberculosis, HPV, and other pathogens, sold globally to clinical labs and health agencies. The company emphasizes affordable, rapid, and accurate testing solutions, with a focus on innovative platform development for point-of-care and at-home use.
This description was generated via AI from an annual report. Updated about 1 year ago.